Literature DB >> 6792342

Surgical selection of infants with gastroesophageal reflux.

D G Johnson, S G Jolley, J J Herbst, L J Cordell.   

Abstract

Gastroesophageal reflux (GER) can produce debilitating and even fatal disease in infants and children. GER is common in infancy, and most GER subsides with time or with postural and dietary therapy. Operation is justified only to control effectively by nonoperative methods. The clinical history and the patient's response to medical treatment remain the most important factors in our decision for or against operation. As in adults, esophagoscopy and esophageal biopsy are useful to document the presence of reflux in older children, but they seldom contribute to the decision for operation in infants. In our hands, gastric scintiscan has provided useful qualitative data on reflux-induced respiratory symptoms and quantitative data on gastric emptying. Esophageal pH monitoring is more quantitative for reflux evaluation and allows analysis and clinical correlations with reflux patterns. We have not used the reflux patterns to predict outcome or response to treatment in the individual patient. A prolonged average duration of reflux during sleep does appear to increase the probability that a patient with respiratory symptoms will respond to operative control of reflux. Our presently imprecise technique for patient selection, however, must not cause us to withhold operation from needy infants. For the infant who does not grow or who aspirates on a reflux board, or who requires prolonged hospitalization and for the preemie who aspirates at every extubation attempts or requires long-term nasojejunal feedings to prevent aspiration, we think antireflux surgery is appropriate, humane, and cost-effective. We see no excuse for persisting with ineffective management of a process that may result in stunting, chronic illness, persistent pain, esophageal scarring, or even respiratory death.

Entities:  

Mesh:

Year:  1981        PMID: 6792342     DOI: 10.1016/0022-3468(81)90010-5

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis.

Authors:  S Cucchiara; A Staiano; G Romaniello; S Capobianco; S Auricchio
Journal:  Arch Dis Child       Date:  1984-09       Impact factor: 3.791

Review 2.  A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. Working Group of the European Society of Paediatric Gastro-enterology and Nutrition (ESPGAN).

Authors:  Y Vandenplas; A Ashkenazi; D Belli; N Boige; J Bouquet; S Cadranel; J P Cezard; S Cucchiara; C Dupont; K Geboes
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

3.  Experience with the Nissen fundoplication for correction of gastroesophageal reflux in infants.

Authors:  J Randolph
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

4.  Gastroesophageal reflux. pH probe-directed therapy.

Authors:  M L Ramenofsky; R W Powell; P W Curreri
Journal:  Ann Surg       Date:  1986-05       Impact factor: 12.969

5.  Diagnostic accuracy of pH monitoring in gastro-oesophageal reflux.

Authors:  L Da Dalt; S Mazzoleni; G Montini; F Donzelli; F Zacchello
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.